|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Discovering drug-drug interactions:a text-mining and reasoning approach basedon properties of drug metabolism显示文摘 | Tari L Anwar S Liang S Cai J Baral C | 2010 | Bioinformatics2010，26，18： | 1 |
| 2 | Fuzzy c-means clustering with prior biological knowledge显示文摘 | Tari L Baral C Kim S | 2009 | Journal of Biomedical Informatics2009，42，1： | 1 |
| 3 | Fuzzy c-means clustering with prior biological knowledge显示文摘 | Tari L Baral C Kim S | 2009 | Journal of Biomedical Informatics2009，42，1： | 1 |
| 4 | Fuzzy c-means clustering with prior biological knowledge显示文摘 | Tari L Baral C Kim S | 2009 | Journal of Biomedical Informafics2009，42，1： | 1 |
| 5 | Discovering drugdrug interactions: a text-mining and reasoning approach based on properties of drug metabolism显示文摘 | Tari L Anwar S Liang S Cai J Baral C | 2010 | Bioinformatics2010，26，18： | 1 |
| 6 | 早期乳腺癌最佳辅助化疗方案与人类表皮生长因子受体2阳性乳腺癌辅助靶向治疗选择:依据 ASCO 对 CCO临床实践指南的改编显示文摘目的研究加拿大安大略癌症治疗中心(CCO)关于早期乳腺癌最佳辅助化疗方案,包括人类表皮生长因子受体2(HER2)阳性乳腺癌辅助靶向治疗方案,并对其进行改编。方法按照美国临床肿瘤协会(ASCO)对其他组织临床实践指南改编的策略和程序,对CCO临床实践指南的严谨性与内容适用性进行回顾。结果基于对CCO临床实践指南内容的回顾,ASCO小组认为,CCO临床实践指南在整体上清晰全面,以最确切的科学证据为基础,为患者提供可接受的治疗选项。推荐关于辅助化疗方案的决定,应考虑到基线复发风险、毒性、利益可能性和宿主因素(如合并症)。对于高风险HER2阴性的身体状况良好的人群,蒽环类和紫杉烷治疗方案是标准治疗方案。4个周期的多西他赛和环磷酰胺治疗方案是可接受的非蒽环类治疗方案。对于高风险HER2阳性患者,推荐蒽环类与紫杉烷序贯疗法联合曲妥单抗或多西他赛、卡铂、曲妥单抗进行6个周期的治疗。对于低风险、非淋巴结转移、HER2阳性人群,推荐每周一次的紫杉醇和曲妥单抗连续进行12个周期的替代治疗。曲妥单抗应持续使用1年。不应采用铂复合盐对三阴性人群进行常规的辅助管理,除非出现有效的生存数据加以支持。 | Neelima Denduluri Mark R Somerfield Andrea Eisen Jamie N Holloway Arti Hurria Tari A King Gary H Lyman Ann H Partridge Melinda L Telli Maureen E Trudeau Antonio C Wolff 本刊编辑部 | 2016 | 中国全科医学2016，19，18： | 1 |
| 7 | Fuzzy C-means clustering with prior biological knowledge显示文摘 | Tari L Baral C Kim S | 2009 | Journal of Bio- medical Informatics2009，42，1： | 1 |
| 8 | Structural Biology of Bacterial Iron Uptake Systems显示文摘 | Clarke T C Tari L W Vogel H J | | 0，，： | 1 |
| 9 | High efficacy of bis- muth subcitrate for Helicobacter pylori eradication in pangas- tritis显示文摘 | Severi C Abdullahi M Tari R | 2009 | Dig Liver Dis2009，41，： | 1 |
| 10 | Fuzzy c-means clustering with prior biological knowledge显示文摘 | Tari L Baral C Kim S | 2009 | Journal of Biomedical Informatics2009，42，1： | 1 |
| 11 | Comparison of depositional sequences and tectonic styles among the West African deepwater frontiers of western lvory Coast, southern Equatorial Guinea, and northern Namibla显示文摘 | Conterill K Tari G C Molnar J | 2002 | The Leading Edge2002，21，11： | 1 |
| 12 | Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells 显示文摘 | Sugimoto T Bartholomeusz C Tari A M | 2007 | Breast Cancer Res2007，9，4： | 1 |
| 13 | Relationship between morphology, rheology and polygalacturonase production by Aspergillus sojae ATCC 20235 in submerged cultures 显示文摘 | GoGUS N TARI C ONCUS | 2006 | Biochemical Engineering Journal2006，3，32： | 1 |
| 14 | Structural basis for the inhibition of Aurora A kinase by a novel class of high af?nity disubstituted pyrimidine inhibitors 显示文摘 | TARI L W HOFFMAN I D BENSEN D C | 2007 | Bioorg Med Chem Lett2007，17，3： | 1 |
| 15 | Fuzzy c- means clustering with prior biological knowledge 显示文摘 | Tari L Baral C Kim S | 2009 | Journal of Biomedical informatics2009，42，1： | 1 |
| 16 | Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells显示文摘 | Tari A M Lim S J Hung M C | 2002 | Oncogene2002，21，34： | 1 |
| 17 | SCADASim-A framework for building SCADA simulations显示文摘 | Queiroz C Mahmood A Tari Z | 2011 | IEEE Transactions on Smart Grid2011，2，4： | 1 |
| 18 | Fuzzy c-means clustering with prior biological knowledge 显示文摘 | Tari L Baral C Kim S | 2009 | Journal of Biomedical Informatics2009，42，1： | 1 |
| 19 | Effects of vacation from work on health and well- being: Lots of fun, quickly gone 显示文摘 | de Bloom J Geurts S A E Taris T W Sonnentag S de Weerth C Kompier M A J | 2010 | Work & Stress2010，24，2： | 1 |
| 20 | Inequity to burnout:The role of job stress显示文摘 | Taris T W Peeters M C LeBlane P M | 2001 | Journal of Occupational Health Psychology2001，，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员